Gene · 1973
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liquid-liquid phase separation in neural development. | Cell Mol Life Sci | 2026 | 41790295 | PubTator, text mining | PubMed |
| P7C3 alleviates hepatic fibrosis via targeting eIF4A1-mediated protein translation and autophagy in hepatic stellate cells. | Arch Pharm Res | 2026 | 41761033 | PubTator, text mining | PubMed |
| CELF1 is a non-canonical eIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAs. | Nucleic Acids Res | 2026 | 41755641 | PubTator, text mining | PubMed |
| Smart Secondary Metabolites in Marine Environments: The Case of Elatol. | Mar Drugs | 2026 | 41745464 | PubTator, text mining | PubMed |
| Eukaryote initiation factor 6 modulates small-cell lung carcinoma plasticity via the integrin-FAK signaling axis. | Nat Commun | 2026 | 41735293 | PubTator, text mining | PubMed |
| TSC2 GAP Domain V1646Cfs*7 Variant Alters Protein Stability and Interaction Networks in Tuberous Sclerosis Complex. | Neurol Genet | 2026 | 41710647 | PubTator, text mining | PubMed |
| A conserved eIF1A+ luminal cell-centered hypoxic and "cold" tumor microenvironment promotes pan-subtype prostate cancer progression. | Cell Rep Med | 2026 | 41707646 | PubTator, text mining | PubMed |
| Functional characterisation of tumour suppressor PDCD4 reveals previously undisclosed role in the control of cell adhesion. | Nucleic Acids Res | 2026 | 41626692 | PubTator, text mining | PubMed |
| Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial. | Nat Commun | 2026 | 41593097 | PubTator, text mining | PubMed |
| Molecular gatekeepers: eukaryotic translation factors decoding plant-virus dynamics for resistance engineering. | Stress Biol | 2026 | 41591594 | PubTator, text mining | PubMed |
| CBL ubiquitin ligase targets translation as a degrader E3. | Chem Sci | 2026 | 41503015 | PubTator, text mining | PubMed |
| Insights into the biological features and improved diagnostics of adult acute myeloid leukemia via fusion genes identified through targeted next-generation sequencing. | Cancer Pathog Ther | 2026 | 41446535 | PubTator, text mining | PubMed |
| TOPK Inhibition Promotes Anti-Tumor Immunity Via eIF4F Complex Mediated STAT1 Translation in Gastric Cancer. | Adv Sci (Weinh) | 2026 | 41417572 | PubTator, text mining | PubMed |
| Interplay between RNA-protein interactions and RNA structures in gene regulation. | FEBS Open Bio | 2026 | 40936360 | PubTator, text mining | PubMed |
| Eukaryotic translation initiation factor 4F: functional properties and physiological role. | Nucleic Acids Res | 2025 | 41404795 | PubTator, text mining | PubMed |
| Peptide antibody tools to dissect specific functions of eIF4A paralogs in cancer. | Discov Oncol | 2025 | 41299109 | PubTator, text mining | PubMed |
| Translation element EIF4A1 is a potential divergent immune biomarker between colon cancer and rectal cancer. | Int J Immunopathol Pharmacol | 2025 | 41268779 | PubTator, text mining | PubMed |
| CXCR4 expression serves as a promising candidate target in the treatment of breast cancer. | Medicine (Baltimore) | 2025 | 41204525 | PubTator, text mining | PubMed |
| Quantitative Reactivity Profiling of Functional Arginine Residues in Human Cancer Cell Line Proteomes. | Angew Chem Int Ed Engl | 2025 | 41116259 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1973/papers?page=2